ARTA
VYGR icon

A.R.T. Advisors’s Voyager Therapeutics VYGR Stock Holding History

A.R.T. Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-47,987
Closed -$669K – 981
2019
Q4 		$669K Sell
47,987
-15,800
-25% -$230K 0.03% 723
2019
Q3 		$1.1M Buy
63,787
+36,800
+136% +$773K 0.06% 512
2019
Q2 		$735K Buy
26,987
+15,900
+143% +$364K 0.04% 586
2019
Q1 		$212K Buy
+11,087
New +$144K 0.01% 1067
2018
Q3 		– Sell
-18,476
Closed -$361K – 1741
2018
Q2 		$361K Sell
18,476
-9,800
-35% -$194K 0.01% 1032
2018
Q1 		$531K Buy
+28,276
New +$611K 0.02% 934

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

A.R.T. Advisors's VYGR Position: Q1 2020 in Review

A.R.T. Advisors sold out of Voyager Therapeutics (VYGR) in Q1 2020, closing a stake of 47,987 shares — an estimated $669K sold.

A.R.T. Advisors first reported a position in VYGR in Q1 2018 and held it in 6 quarters. The position peaked at $1.1M in Q3 2019. 121 funds tracked by Wall St. Rank hold VYGR as of Q1 2020.

  • A.R.T. Advisors reported no remaining Voyager Therapeutics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 47,987 Voyager Therapeutics shares in Q1 2020, an estimated $669K.
  • A.R.T. Advisors first reported a position in Voyager Therapeutics in Q1 2018 and held it in 6 quarters.
  • A.R.T. Advisors's Voyager Therapeutics position peaked at $1.1M in Q3 2019.
  • 121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.